ArticleCancer research communications2024

Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models.

Zhanfang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.